Abstract
Objective: This study aimed to analyze the cost-effectiveness of the GERD treatment management strategy for class II inpatient patients at a police hospital in Bandung, Indonesia.
 Methods: This study was retrospective, using medical record data collection techniques for 103 patients of the Social Security Administrator for Health (Badan Penyelenggara Jaminan Sosial, BPJS), from January 2017 to July 2019. The pharmacoeconomic method was Cost-Effectiveness Analysis. The medicines being compared were omeprazole injection and pantoprazole injection. The outcome parameter was the length of stay (LOS). The perspective was a hospital with a direct cost component. This study uses a 5% discounting rate due to differences in years.
 Results: The results showed that the patient majority was female (76%) and the largest age group was>40 y (53%). There was a significant difference in LOS and total cost between omeprazole and pantoprazole (p-value<0.050) using the Mann-Whitney test. The cost-effectiveness ratio showed that omeprazole has a higher value than pantoprazole.
 Conclusion: Therapy using pantoprazole was more cost-effective than omeprazole.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
